ZNF225 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.398400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.881600E-01
Normal-vs-Stage2
9.940400E-02
Normal-vs-Stage3
1.380630E-01
Normal-vs-Stage4
7.474000E-01
Stage1-vs-Stage2
3.542600E-01
Stage1-vs-Stage3
6.646100E-02
Stage1-vs-Stage4
7.092600E-01
Stage2-vs-Stage3
3.240700E-03
Stage2-vs-Stage4
1.913950E-01
Stage3-vs-Stage4
1.025820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.563600E-02
Normal-vs-AfricanAmerican
2.233000E-01
Normal-vs-Asian
1.400160E-01
Caucasian-vs-AfricanAmerican
8.507600E-01
Caucasian-vs-Asian
4.915400E-01
AfricanAmerican-vs-Asian
6.024000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.440300E-02
Normal-vs-Female
1.244370E-01
Male-vs-Female
5.120200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.875800E-01
Normal-vs-Age(41-60Yrs)
2.593600E-01
Normal-vs-Age(61-80Yrs)
6.100400E-02
Normal-vs-Age(81-100Yrs)
4.636000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.855400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.009200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.539000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.735620E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.052300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.582800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.926500E-02
Normal-vs-Daily Drinker
2.856300E-02
Normal-vs-Weekly Drinker
8.154100E-02
Normal-vs-Occasional Drinker
2.482600E-01
Normal-vs-Social Drinker
1.121050E-01
Non Drinker-vs-Daily Drinker
8.804800E-01
Non Drinker-vs-Weekly Drinker
7.149400E-01
Non Drinker-vs-Occasional Drinker
7.169900E-02
Non Drinker-vs-Social Drinker
2.828200E-01
Daily Drinker-vs-Weekly Drinker
6.382000E-01
Daily Drinker-vs-Occasional Drinker
6.936100E-02
Daily Drinker-vs-Social Drinker
2.479400E-01
Weekly Drinker-vs-Occasional Drinker
2.490200E-01
Weekly Drinker-vs-Social Drinker
5.622800E-01
Occasional Drinker-vs-Social Drinker
5.246400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.027240E-01
Normal-vs-Grade 2
2.922500E-02
Normal-vs-Grade 3
3.872200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.104000E-01
Grade 1-vs-Grade 3
8.356600E-01
Grade 1-vs-Grade 4
1.027240E-01
Grade 2-vs-Grade 3
6.535000E-01
Grade 2-vs-Grade 4
2.922500E-02
Grade 3-vs-Grade 4
3.872200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.584350E-02
Normal-vs-NonDiabetic
8.073700E-02
Diabetic-vs-NonDiabetic
1.586770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.361900E-02
Normal-vs-NoPancreatitis
5.346500E-02
Pancreatitis-vs-NoPancreatitis
3.986000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.021790E-01
Normal-vs-N1
9.876400E-02
N0-vs-N1
5.445400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.804400E-01
Normal-vs-TP53-NonMutant
2.719000E-01
TP53-Mutant-vs-TP53-NonMutant
9.943000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
